retatrutide clinical trials retatrutide Eli Lilly infiltrates anti-obesity market as Phase III trial for begins Doctor Comment: Eli Lilly Drug

The brand keeps it simple, and honestly, that helps

Patients who are not a candidate for Semaglutide are patients who have a history of diabetes (Semaglutide could make your blood sugar too low), patients who have a history of medullary thyroid cancer, and patients who have a personal or family history of Multiple Endocrine Neoplasia Syndrome type 2

With the right shot-day routine, you can stay on track, minimize side effects, and feel empowered every step of the way

Eli Lilly has announced that Phase 3 clinical trials (the TRIUMPH programme ) are underway, investigating retatrutide across a broader population and over longer timeframes